Vitro, S.A.B. de C.V. (BMV:VITRO.A)
Mexico · Delayed Price · Currency is MXN 4.850
0.00 (0.00%)
Nov 6, 2026, 2:19 PM CST
Vitro Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 288.45 | 282.03 | 284.15 | 310.65 | 251.81 | 1,958 | |
Revenue Growth | 135.94% | -0.75% | -8.53% | 23.37% | -87.14% | 10.70% |
Cost of Revenue | 178.06 | 180.73 | 164.11 | 161.62 | 110.93 | 1,520 |
Gross Profit | 110.39 | 101.3 | 120.05 | 149.03 | 140.87 | 437.77 |
Selling, General & Admin | 127.52 | 119.99 | 117.22 | 116.97 | 94.44 | 376.24 |
Other Operating Expenses | -2.94 | -2.99 | 0.24 | 4.04 | -0.77 | 4.35 |
Operating Expenses | 124.58 | 117 | 117.47 | 121.01 | 93.67 | 380.59 |
Operating Income | -14.19 | -15.71 | 2.58 | 28.03 | 47.21 | 57.18 |
Interest Expense | -16.14 | -27.38 | -31.1 | -35.02 | -30.54 | -27.52 |
Interest & Investment Income | 27.03 | 42.37 | 43.27 | 55.81 | 49.79 | 2.65 |
Earnings From Equity Investments | -1.95 | -1.95 | 7.17 | 0.15 | 0.1 | -4.58 |
Currency Exchange Gain (Loss) | 23.59 | 86.3 | -148.19 | 97.37 | 32.58 | -7.23 |
Other Non Operating Income (Expenses) | 46.64 | 41.77 | 15 | -4.08 | -8.57 | -31.43 |
EBT Excluding Unusual Items | 64.99 | 125.4 | -111.26 | 142.27 | 90.57 | -10.93 |
Merger & Restructuring Charges | - | - | - | - | - | -11.4 |
Impairment of Goodwill | - | - | - | - | - | -4.58 |
Gain (Loss) on Sale of Assets | 0.06 | 0.06 | -0.68 | 3 | 10.89 | -9.71 |
Asset Writedown | 25.64 | 25.64 | - | 6.04 | -31.7 | -45.42 |
Pretax Income | 90.68 | 151.09 | -111.95 | 151.3 | 69.76 | -82.04 |
Income Tax Expense | -1.74 | 21.48 | -15.33 | 28.69 | 37.08 | 24.85 |
Earnings From Continuing Operations | 92.41 | 129.62 | -96.62 | 122.61 | 32.68 | -106.9 |
Earnings From Discontinued Operations | 22.12 | - | - | 6.53 | -15.3 | - |
Net Income to Company | 114.53 | 129.62 | -96.62 | 129.15 | 17.38 | -106.9 |
Minority Interest in Earnings | - | - | - | - | - | 0.3 |
Net Income | 114.53 | 129.62 | -96.62 | 129.15 | 17.38 | -106.6 |
Net Income to Common | 114.53 | 129.62 | -96.62 | 129.15 | 17.38 | -106.6 |
Net Income Growth | 79.71% | - | - | 642.90% | - | - |
Shares Outstanding (Basic) | 554 | 470 | 470 | 470 | 470 | 471 |
Shares Outstanding (Diluted) | 554 | 470 | 470 | 470 | 470 | 471 |
Shares Change | 67.51% | - | - | - | -0.30% | -0.57% |
EPS (Basic) | 0.21 | 0.28 | -0.21 | 0.27 | 0.04 | -0.23 |
EPS (Diluted) | 0.21 | 0.28 | -0.21 | 0.27 | 0.04 | -0.23 |
EPS Growth | 7.28% | - | - | 642.90% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 143.69 | 113.29 | 62.35 | 256.43 | 267.36 | -121.68 |
Free Cash Flow Per Share | 0.26 | 0.24 | 0.13 | 0.55 | 0.57 | -0.26 |
Dividend Per Share | - | - | - | 1.128 | 0.064 | 0.021 |
Dividend Growth | - | - | - | 1667.40% | 200.94% | -41.18% |
Gross Margin | 38.27% | 35.92% | 42.25% | 47.97% | 55.95% | 22.36% |
Operating Margin | -4.92% | -5.57% | 0.91% | 9.02% | 18.75% | 2.92% |
Profit Margin | 39.71% | 45.96% | -34.00% | 41.57% | 6.90% | -5.45% |
Free Cash Flow Margin | 49.81% | 40.17% | 21.94% | 82.55% | 106.18% | -6.22% |
EBITDA | 6.38 | 5.88 | 14.93 | 41.05 | 165.77 | 180.82 |
EBITDA Margin | 2.21% | 2.08% | 5.25% | 13.21% | 65.83% | 9.24% |
D&A For EBITDA | 20.57 | 21.59 | 12.35 | 13.03 | 118.57 | 123.64 |
EBIT | -14.19 | -15.71 | 2.58 | 28.03 | 47.21 | 57.18 |
EBIT Margin | -4.92% | -5.57% | 0.91% | 9.02% | 18.75% | 2.92% |
Effective Tax Rate | - | 14.21% | - | 18.96% | 53.15% | - |